Serum Lipid Profile and Lip Squamous Cell Carcinoma
NCT07005115 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2025-06-06
Summary
The goal of this observational retrospective study is to assess whether serum lipid levels differ between patients diagnosed with lip squamous cell carcinoma (SCC) and healthy individuals. The study aims to evaluate if alterations in lipid parameters, especially LDL levels, are associated with the presence of lip SCC and could serve as potential early biomarkers.
The main research questions are:
Do patients with lip SCC show significantly lower LDL levels compared to healthy controls? Are there significant differences in total cholesterol (TC), triglycerides (TG), HDL, and VLDL between the two groups? A retrospective analysis was conducted using existing medical records of patients with lip SCC and healthy subjects obtained from 2018-2023.
Conditions
- Lipid Profile
- Lipids
- SCC - Squamous Cell Carcinoma
- Lip Cancer
- Oral Cancer
Sponsors & Collaborators
-
Akdeniz University
lead OTHER
Principal Investigators
-
Eldar Rasljanin, DDS · Akdeniz University, Antalya, Turkiye
-
Özer Erdem Gür, MD · Antalya Training and Research Hospital, University of Health Science, Antalya, Turkiye
-
Rezarta Taga Senirli, MD · Antalya Training and Research Hospital, University of Health Science, Antalya, Turkiye
-
Busehan Bilgin, DDS · Akdeniz University, Antalya, Turkiye
-
Öznur Özalp, DDS · Akdeniz University, Antalya, Turkiye
-
Mehmet Ali Altay, DDS, PhD · Akdeniz University, Antalya, Turkiye
-
Alper Sindel, DDS, PhD · Akdeniz University, Antalya, Turkiye
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2021-01-01
- Completion
- 2023-01-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Nutritional Status of Head and Neck Cancer Patients
NCT07068711 ·Status: RECRUITING
-
Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
NCT01084733 ·Status: COMPLETED
-
Head and Neck Cancer in Children: A Retrospective Study
NCT02557048 ·Status: UNKNOWN
-
Investigating the Effects of Orienting Skin Grafts Parallel to Skin Tension Lines on Quality of Life in Head and Neck Located Basal Cell Carcinoma
NCT06894056 ·Status: COMPLETED
-
Study of SCB01A in Patient With Head and Neck Cancer
NCT02488629 ·Status: TERMINATED ·Phase: PHASE2
-
Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
NCT01919567 ·Status: UNKNOWN
-
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
NCT05123950 ·Status: COMPLETED
-
Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02705833 ·Status: COMPLETED
-
Neck Surgery in Treating Patients With Early-Stage Oral Cancer
NCT00571883 ·Status: UNKNOWN ·Phase: NA
-
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
NCT05125055 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00098631 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6
NCT03356223 ·Status: COMPLETED ·Phase: PHASE2
-
Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma
NCT05595265 ·Status: UNKNOWN
-
Needs and Preferences of Patients With Head-neck Cutaneous SCC
NCT06046625 ·Status: ACTIVE_NOT_RECRUITING
-
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
NCT05929547 ·Status: NOT_YET_RECRUITING
-
Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma
NCT06465030 ·Status: RECRUITING
-
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
NCT04528420 ·Status: RECRUITING ·Phase: NA
-
Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck
NCT01301248 ·Status: UNKNOWN ·Phase: PHASE2
-
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT02281955 ·Status: COMPLETED ·Phase: PHASE2
-
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT02035527 ·Status: COMPLETED ·Phase: PHASE1
-
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
NCT06380686 ·Status: RECRUITING
-
Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma
NCT00772681 ·Status: COMPLETED ·Phase: PHASE4
-
Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention
NCT02869399 ·Status: COMPLETED ·Phase: NA
-
Impact of Ribociclib on Head and Neck Squamous Cell Cancer
NCT03179956 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN
NCT03117257 ·Status: UNKNOWN ·Phase: PHASE2